Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): Randomised double-blind active-controlled trial: Commentary, author response
Date
2025
Authors
Loo, C.
Alonzo, A.
Barton, D.
Berk, M.
Chatterton, M.L.
Dong, V.
Gálvez, V.
Mills, N.T.
Mitchell, P.B.
Sarma, S.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
The British journal of psychiatry. Supplement, 2025; 226(5):317-318
Statement of Responsibility
Colleen Loo, Angelo Alonzo, David Barton, Michael Berk, Mary Lou Chatterton, Vanessa Dong, Veronica Gálvez, Natalie T. Mills, Philip B. Mitchell, Shanthi Sarma, Andrew A. Somogyi, and Anthony Rodgers
Conference Name
Abstract
Abstract is not available
School/Discipline
Dissertation Note
Provenance
Description
Commentary
Access Status
Rights
© The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists.